U.S. FDA approves Vanda's circadian rhythm drug Hetlioz

(Reuters) - Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its experimental drug to regulate the internal body clocks of blind patients and help normalize sleep patterns.

via Reuters: Health News Read More Here..